Patient nonadherence to medication in inflammatory bowel disease

被引:246
作者
Sewitch, MJ
Abrahamowicz, M
Barkun, A
Bitton, A
Wild, GE
Cohen, A
Dobkin, PL
机构
[1] Univ Montreal, Fac Med, Grp Rech Interdisciplinaire Sante, Montreal, PQ H3C 3J7, Canada
[2] Montreal Gen Hosp, Div Clin Epidemiol, Montreal, PQ H3G 1A4, Canada
[3] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[4] McGill Univ, Dept Med, Montreal, PQ, Canada
关键词
D O I
10.1016/S0002-9270(03)00304-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: The aim of this study was to identify determinants of nonadherence to medication in outpatients with established inflammatory bowel disease (IBD). METHODS: Ten gastroenterologists and 153 of their IBD patients participated in this prospective study. Demographic, clinical, and psychosocial characteristics, as well as patient-physician discordance, were assessed at an office visit. Nonadherence to medication was assessed 2 wk later. Separate generalized estimating equations were used to identify determinants of nonadherence. RESULTS: Physicians averaged 47.9 yr in age (range 30.1-57.5 yr), and 90% were male. Patients averaged 37.0 yr (SD = 15.1). and 87 (56.9%) were female. In all, 63 patients (41.2%) were nonadherent to medication; of these, 51 (81.0%) indicated unintentional nonadherence, 23 (36.5%) intentional nonadherence, and 11 (17.5%) both. Overall nonadherence was predicted by disease activity (OR = 0.55, p = 0.0022), new patient status (OR = 2.14, p = 0.0394), disease duration (OR = 0.50, p = 0.0001), and scheduling a follow-up appointment (OR = 0.30, p = 0.0059), whereas higher discordance on well-being was predictive only in psychologically nondistressed patients (p = 0.0026 for interaction). Unintentional nonadherence was predicted by age (OR = 0.97, p = 0.0072), new patient status (OR = 2.80, p = 0239), and higher discordance on well-being in psychologically nondistressed patients (p = 0.0504). Intentional nonadherence was predicted by disease duration (OR = 0.55, p = 0032), scheduling a follow-up appointment (OR = 0.12, p = 0.0001), certainty that medication would be helpful (OR = 0.99, p 0.0409), and total patient-physician discordance (OR = 1.59, p = .0120). CONCLUSIONS: These findings suggest that the therapeutic relationship, as well as individual clinical and psychosocial characteristics, influence adherence to medication. (C) 2003 by Am. Coll. of Gastroenterology.
引用
收藏
页码:1535 / 1544
页数:10
相关论文
共 84 条
[51]   RECALL OF RECOMMENDATIONS AND ADHERENCE TO ADVICE AMONG PATIENTS WITH CHRONIC MEDICAL CONDITIONS [J].
KRAVITZ, RL ;
HAYS, RD ;
SHERBOURNE, CD ;
DIMATTEO, MR ;
ROGERS, WH ;
ORDWAY, L ;
GREENFIELD, S .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (16) :1869-1878
[52]   Methotrexate for the treatment of refractory Crohn's disease [J].
Lemann, M ;
ChamiotPrieur, C ;
Mesnard, B ;
Halphen, M ;
Messing, B ;
Rambaud, JC ;
Gendre, JP ;
Colombel, JF ;
Modigliani, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) :309-314
[53]   LONGITUDINAL DATA-ANALYSIS USING GENERALIZED LINEAR-MODELS [J].
LIANG, KY ;
ZEGER, SL .
BIOMETRIKA, 1986, 73 (01) :13-22
[54]   Differences between patients' and physicians' evaluations of outcome after total hip arthroplasty [J].
Lieberman, JR ;
Dorey, F ;
Shekelle, P ;
Schumacher, L ;
Thomas, BJ ;
Kilgus, DJ ;
Finerman, GA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1996, 78A (06) :835-838
[55]  
Liu HH, 2002, ANN INTERN MED, V137, P72, DOI 10.7326/0003-4819-137-1-200207020-00024
[56]   Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease [J].
Mahmud, N ;
McDonald, GSA ;
Kelleher, D ;
Weir, DG .
GUT, 1996, 38 (01) :99-103
[57]  
Meichenbaum D., 1987, FACILITATING TREATME
[58]   CONCURRENT AND PREDICTIVE-VALIDITY OF A SELF-REPORTED MEASURE OF MEDICATION ADHERENCE [J].
MORISKY, DE ;
GREEN, LW ;
LEVINE, DM .
MEDICAL CARE, 1986, 24 (01) :67-74
[59]   Patient-physician agreement on reasons for outpatient visits [J].
Murden, RA ;
Kreger, CG .
MAYO CLINIC PROCEEDINGS, 1999, 74 (01) :105-106
[60]  
Neville C, 2000, J RHEUMATOL, V27, P675